Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitotic spindle microtubules are dynamic polymers of alpha- and beta-tubulin heterodimers that provide the physical framework for chromosome segregation during cell division (StatPearls, 2023). The broader mitosis machinery includes motor proteins like kinesins and regulatory kinases such as Aurora and Polo-like kinases, which ensure the high-fidelity distribution of genetic material (Nature Reviews Molecular Cell Biology, 2011). These components are classic therapeutic targets in oncology because their disruption prevents cancer cells from completing mitosis, leading to cell cycle arrest and apoptosis (PubMed, PMC3595324). Microtubule-targeting agents (MTAs) are broadly classified into stabilizers, such as taxanes, and destabilizers, such as vinca alkaloids (PubChem). While highly effective against various solid tumors and hematologic malignancies, these agents often cause off-target effects in non-dividing cells. Most notably, they cause peripheral neuropathy due to the disruption of microtubule-dependent axonal transport in neurons (NIH, 2022). Modern research also focuses on more specific machinery proteins, like Kinesin Spindle Protein (KSP), to reduce the systemic toxicity associated with general tubulin inhibition.
Disruption of microtubule dynamic instability through either stabilization or inhibition of polymerization, resulting in spindle assembly checkpoint activation, mitotic arrest, and apoptosis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin and mitotic spindle machinery proteins.